Potential Cost Savings by Switching from Subcutaneous to Intralymphatic Insect Venom Immunotherapy.

Chabot, Alexandra; Lang, Claudia; Kündig, Thomas M; Schmid-Grendelmeier, Peter; Johansen, Pål

Chabot, Alexandra; Lang, Claudia; Kündig, Thomas M; Schmid-Grendelmeier, Peter; Johansen, Pål.

Afiliação

Chabot A; Department of Dermatology, University of Zurich, Zurich, Switzerland.
Lang C; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Kündig TM; Department of Dermatology, University of Zurich, Zurich, Switzerland.
Schmid-Grendelmeier P; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Johansen P; Department of Dermatology, University of Zurich, Zurich, Switzerland.

Int Arch Allergy Immunol ; 184(10): 985-993, 2023.

Article em En | MEDLINE | ID: mdl-37467738

Palavras-chave

Allergy; Cost analysis; Intralymphatic immunotherapy; Venom immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation Idioma: En Revista: Int Arch Allergy Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google